mast cell tumor
mutations in KIT, MDR1, and VEGFR2
lymphoma
mutations in TRAF3 and PTEN
oral melanoma
mutations in KIT, MDM2, and NRAS
histiocytic sarcoma
mutations in PTPN11 and TP53
lung adenocarcinoma
mutation in HER2
Our Diagnostic
Our flagship test, SearchLight DNA, is an extensively validated, next-generation diagnostic test that checks for 120 relevant cancer genes, making it the most informative and scientifically rigorous canine cancer genetic test available.
Our specialty pathology team combines extensive expertise in cancer pathology with genomic diagnostics to provide unparalleled advanced cancer diagnostic evaluation for your patients.
Life-saving statistics
50%
50% of dogs over the age of 10 develop cancer at some point.
80%
Osteosarcoma accounts for approximately 80% of the primary bone cancers found in dogs and is one of the most common cancer types in canines.
20%
Lymphoma is one of the most common cancers seen in dogs, accounting for 20% of all canine cancers.
6 Million
More dogs (6 million) than humans (1.8 million) will be diagnosed with cancer this year in the United States.
94%
Around 94% of the cancer genome is arranged analogously to the human (genome).
1 in 4
1 in 4 dogs will be diagnosed with cancer during their lifetime.
